Search

A team of researchers from MSK and Weill Cornell Medicine is expanding the understanding of how a decades-old treatment for bladder cancer works — an understanding that could help improve the effectiveness of immunotherapies more broadly.

… Thursday, May 29, 2025 More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat early-stage bladder cancer. Now, a team of researchers from Memorial Sloan Kettering Cancer

Electronic nose (e-nose) technology identified early-stage lung cancer with high reliability in a prospective observational clinical trial conducted at Memorial Sloan Kettering Cancer Center (MSK).

… Friday, June 7, 2024 Electronic nose (e-nose) technology identified early-stage lung cancer with high reliability in a prospective observational clinical trial conducted at Memorial Sloan Kettering Cancer Center (MSK). E-nose diagnostic predictions agreed with histopathological results in 86% of 100

Researchers find an epigenetic role in how breast cancer tumors develop resistance to treatment.

… Thursday, March 23, 2017 Summary Many breast cancers rely on a disease pathway called PI3K, so drugs have been developed to inhibit this pathway. However, after responding initially to PI3K inhibitors, these tumors often activate another pathway, called ER, to begin growing again. A new finding reveals

MSK's new clinic will focus on clonal hematopoiesis, a condition related to aging that increases the risk of developing certain blood cancers.

… Tuesday, January 23, 2018 Summary The clinic will focus on clonal hematopoiesis. This age-related condition increases the risk of developing certain blood cancers. Most cancers arise by chance and, therefore, are hard to predict. But scientists and doctors are learning more about the genetic changes

People who maintain a healthy lifestyle after surgery and chemotherapy for colon cancer are more likely to have a favorable outcome after treatment.

… Thursday, June 1, 2017 Summary People who maintain a healthy lifestyle after surgery and chemotherapy for colon cancer are more likely to have a favorable outcome after treatment. Findings from two studies demonstrating this are being presented at the ASCO meeting. Highlights One study found that consumption

Memorial Sloan Kettering and Bright Horizons, the nation’s largest provider of employer-sponsored childcare, recently opened a new, state-of-the-art childcare facility for exclusive use of MSK employees.

… Monday, March 8, 2021 Memorial Sloan Kettering Cancer Center (MSK) and Bright Horizons, the nation’s largest provider of employer-sponsored childcare, recently opened a new, state-of-the-art childcare facility for exclusive use of MSK employees. Located only a few short blocks from MSK’s flagship location

The Gerstner Sloan Kettering Summer Undergraduate Research Program (SURP) will welcome 25 students to this year's ten-week program.

… Sunday, May 1, 2011 Designed to allow outstanding undergraduate students to obtain hands-on research experience in Memorial Sloan Kettering laboratories, the 2011 Summer Undergraduate Research Program will have a class of 13 women and 12 men — one freshman, seven sophomores, and 17 juniors — who are

Memorial Sloan Kettering Cancer Center (MSK) today announced a transformative gift from the Commonwealth Foundation for Cancer Research to benefit the Center for Experimental Therapeutics, a multidisciplinary research and drug development group at MSK. With this gift, the Commonwealth Foundation for Cancer Research continues their nearly three-decade commitment to the Center for Experimental Therapeutics, which was initially founded in 2002 with a generous gift from the Foundation.

… Wednesday, September 13, 2023 Memorial Sloan Kettering Cancer Center (MSK) today announced a transformative gift from the Commonwealth Foundation for Cancer Research to benefit the  Center for Experimental Therapeutics , a multidisciplinary research and drug development group at MSK. With this gift,

The May 6 session of “MSK Science Spotlight” features Ross Levine, MD, Laurence Joseph Dineen Chair in Leukemia Research and Chief, Molecular Cancer Medicine Service, Human Oncology and Pathogenesis Program, presenting his work on “Deciphering and Targeting Clonal Evolution.”

… Wednesday, May 6, 2020 The May 6 session of “ MSK Science Spotlight ” features Ross Levine, MD , Laurence Joseph Dineen Chair in Leukemia Research and Chief, Molecular Cancer Medicine Service, Human Oncology and Pathogenesis Program, presenting his work on “Deciphering and Targeting Clonal Evolution.

As we celebrate National Nurses Week, Memorial Sloan Kettering Cancer Center (MSK) and The Robbins Family Foundation recognize seven distinguished nursing staff members for their exemplary service. Each member of this select group is being honored with the inaugural 2020 Robbins Family Award for Nursing Excellence.

… Monday, May 11, 2020 Jessica Agostini Jessica Agostini Joseph Kesselbrenner Joseph Kesselbrenner Meghan Salcedo Meghan Salcedo Jennifer Fox Jennifer Fox Kristen Fessele Kristen Fessele Andrea Smith Andrea Smith Leon Chen Leon Chen As we celebrate National Nurses Week, Memorial Sloan Kettering Cancer